| Literature DB >> 17692119 |
Ishag Adam1, Saud Babiker, Ahmed A Mohmmed, Magdi M Salih, Martin H Prins, Zaki M Zaki.
Abstract
BACKGROUND: Understanding the pathogenesis of malaria in pregnancy and its consequences for both the mother and the baby is fundamental for improving malaria control in pregnant women. AIM: The study aimed to investigate the role of ABO blood groups on pregnancy outcomes in an area of unstable malaria transmission in eastern Sudan.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17692119 PMCID: PMC1988824 DOI: 10.1186/1475-2875-6-110
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
ABO phenotype by placental malaria category and parity group
| Parity | Placental malaria | Blood group Phenotype | ||||
| Type | number | A | B | AB | O | |
| Total | Acute | 6 | 5 (6.1) | 1(1.7) | 0 (0) | 0 (0) |
| Chronic | 6 | 2(2.4) | 1(1.7) | 1(4.2) | 2(1.6) | |
| Past | 82 | 19(23.2) | 13(22.0) | 5(20.8) | 45(35.2)* | |
| None | 199 | 56 (68.3) | 44(74.6) | 18(75) | 81(63.3) | |
| Total | 293 | 82 | 59 | 24 | 128 | |
| Primiparae | Acute | 2 | 2(6.5) | 0(0) | 0(0) | 0(0) |
| Chronic | 1 | 0(0) | 0(0) | 1(12.5) | 0(0) | |
| Past | 26 | 5(16.1) | 3(12.5) | 2 (25.0) | 16(31.4)* | |
| None | 85 | 24(77.4) | 21(87.5) | 5(62.5) | 35(68.6) | |
| Total | 114 | 31 | 24 | 8 | 51 | |
| Secundiparae | Acute | 2 | 1(4.2) | 1(12.5) | 0(0) | 0(0) |
| Chronic | 0 | 0(0) | 0(0) | 0(0) | 0(0) | |
| Past | 18 | 8(33.3) | 0(0) | 0(0) | 10(38.5) | |
| None | 41 | 15(62.5) | 7(87.5) | 3(100) | 16(61.5) | |
| Total | 61 | 24 | 8 | 3 | 26 | |
| Multiparae | Acute | 2 | 2(7.4) | 0 | 0 | 0 |
| Chronic | 5 | 2(7.4) | 1(3.7) | 0 | 2(3.9) | |
| Past | 38 | 6(22.2) | 10(37) | 3(23.1) | 19(37.3) | |
| None | 73 | 17(63.0) | 16(59.3) | 10(76.9) | 30(58.8) | |
| Total | 118 | 27 | 27 | 13 | 51 | |
* Significant difference
Mean (SD) maternal and birth outcomes by parity and maternal blood group phenotype
| Parity | Maternal and foetal parameters | |||||
| Placental malaria type | Blood group | number | Maternal Hb | Birth weight | Foeto-placental ratio | |
| All parity | Infection | Group O | 47 | 11.8(2.1)* | 3060.1(370.0) | 5.4(1.0) |
| Non-O | 47 | 10.9(1.9 | 310.9(575.4) | 5.6(1.0) | ||
| No infection | Group O | 81 | 11.5(2.1) | 3098.3(561.6) | 5.7(1.1) | |
| Non-O | 118 | 11.6(2.2) | 3037.2(554.2) | 5.6(1.4) | ||
| Primiparae | Infection | Group O | 16 | 12.0(2.0)* | 2946.4(367.2) | 5.6(0.8) |
| Non-O | 13 | 10.4(2.3) | 2898.3(409.7) | 5.7(0.9) | ||
| No infection | Group O | 35 | 11.1(2.1) | 3065.4(462.4) | 5.8(1.0) | |
| Non-O | 50 | 11.7(2.3) | 3019.8(593.9) | 5.8(1.8) | ||
| Secundiparae | Infection | Group O | 10 | 11.1(2.5) | 3150.1(348.4) | 5.7(0.3) |
| Non-O | 10 | 11.0(1.2) | 3298.6(655.0) | 5.5(1.3) | ||
| No infection | Group O | 16 | 11.5(1.9) | 3251.2(570.5) | 6.0(1.2) | |
| Non-O | 25 | 12.1(2.1) | 2947.4(529.9) | 5.4(1.0) | ||
| Multiparae | Infection | Group O | 21 | 12.0(2.0) | 3098.5(379.2) | 5.1(0.98) |
| Non-O | 24 | 11.1(2.0) | 3038.0(604.4) | 5.5(1.3) | ||
| No infection | Group O | 30 | 11.9(2.1) | 3055.6(656.9) | 5.4(1.1) | |
| Non-O | 43 | 11.2(2.0) | 3109.524.8) | 5.3(0.9) | ||
* Significant difference